Key result
Magellan and Angel PRP devices achieve similar ~6-fold platelet concentrations in cardiac surgery.
RCT (n=60)
Single-blind
Coin toss
No
Answers are grounded in this paper and cite their sources.
Investigations assess accuracy of PRP devices in cardiac surgery, suggesting effective wound healing outcomes.
Background: Applying platelet rich plasma (PRP) to the sternum immediately prior to approximation has been shown to enhance wound healing, lower the incidence of sternal wound infections, reduce costs associated with treating these infections and decrease post-operative pain scores. Multiple investigations have reported device-specific outcomes regarding PRP preparation yields from healthy volunteer blood donors, all with initial platelet counts in the normal range. What is missing from the literature is how accurately PRP preparations reflect device-specific yield target values, particularly under the clinical conditions encountered routinely in the cardiac surgery arena. Methods: The Magellan® group (30 cases) and the Angel® group (30 cases) comprised the two study groups (2 groups, 60 total cases,120 samples total). Pre and post processing blood samples from each group were analyzed for platelet counts. Platelet count increases were assessed for accuracy when compared to a specific target. Results: Individual yields from each tested device demonstrated some degree of limited variability. However, both groups mean values achieved and slightly exceeded the target value of a six-fold increase; Magellan group (M=6.58, SD=1.33), Angel group (M=6.31, SD=0.93). Conclusion: Both devices, on average, appear capable of accurately preparing PRP to meet the specific target value of a six-fold increase over baseline under conditions routinely encountered in cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Garrison et al. (2026) conducted an RCT in Cardiac surgery requiring autologous platelet-rich plasma preparation (n=60). Magellan Autologous Concentration System vs. Angel cPRP System (7% Hct protocol, 18 mL total PRP targeting 6x baseline platelet count) was evaluated on Mean platelet count yield multiple (times baseline) compared to a 6x target (p=0.35). Magellan and Angel PRP devices both achieved the 6-fold baseline platelet concentration target in cardiac surgery patients, with mean yield multiples of.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: